Start-up
SOLID Therapeutics
About SOLID Therapeutics
SOLID Therapeutics is an early-stage oncology company which is based on research at University of Copenhagen joining expertise in metabolite GPCR structure-based drug discovery in the Schwartz-Frimurer labs at the Novo Nordisk Foundation (NNF) Center for Basic Metabolic Research (CBMR) with the deep insight into cell biology of the tumor microenvironment in the Falsig Petersen lab. The concept of HCAR1 antagonists as anti-cancer drugs was supported by an Exploratory Pre-Seed grant from NNF, a Pre-Seed grant from the Bioinnovation Institute (BII) and an Innobooster grant from Innovationsfonden. The company was officially founded in March 2022 when accepted into the Venture Lab at BII.
- Founding: 2022
- Focus : Manufacturer
- Employees: 1-10
- Industry : Biotechnology, Pharma
Advertisement
Product portfolio of SOLID Therapeutics
News about SOLID Therapeutics
Here you will find SOLID Therapeutics
Last viewed contents
Genicity - Newcastle, Galway, United Kingdom
Colorectal cancer screening via smartphone? - App-based early detection is as accurate as laboratory tests and could motivate more people to undergo screening
Mobile One Health laboratory for diagnosing highly pathogenic pathogens
Berlin-based blood analysis innovator aescolab secures new capital - Start-up uses AI for personalized health analyses
Ear wax as a possible screening medium for Parkinson’s disease
Making fibrosis visible – before it’s too late - With planned ETH spin-off to market maturity
New nanosensors make diagnostic procedures more sensitive - The nanosensors can be used to track reactions with invisible light, saving materials and time
Cyber Valley grants 500K to CELL’n’ROLL via 2023 Innovation Fellowship Program - Cyber Valley Community is advancing diagnostics for the future: Its goal is to create an innovative spin-off from the project after the funding term has ended
Blood diagnostics modelled on leeches - For all those who are afraid of needles: New device for taking blood samples uses microneedles and a suction cup instead of a large needle
AI personalises brain tumour therapy - Progress in the personalised treatment of brain tumours: AI identifies mutations
En Carta Diagnostics secures €1.5M to advance diagnostic kit platform for early Lyme disease detection - Groundbreaking patented molecular diagnostic kit poised to provide game-changing autonomous Lyme detection in minutes
